omniture
Porda Havas International Financial Communications Group

Latest News

Sihuan Pharmaceutical's Gabapentin Capsules was Granted Drug Production Approval, the Third Company Obtained Approval in China

HONG KONG, Oct. 22, 2020 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd.(the "Company'' o...

2020-10-22 10:36 10934

Sihuan Pharmaceutical Invests in Phase I Fund of Ascendum Capital Life Technology to Expand its Strategy in Development of Innovative Drugs

HONG KONG, Oct. 20, 2020 /PRNewswire/ -- On 20 October 2020, Sihuan Pharmaceutical Holdings Group L...

2020-10-20 11:09 5782

JHBP (CY) Holdings Limited (6998.HK) Successfully listed on the Main Board of SEHK

HONG KONG, Oct. 7, 2020 /PRNewswire/ -- JHBP (CY) Holdings Limited ("Genor Biopharma"or the "Compan...

2020-10-07 18:05 8158

Announcement of Memorandum of Understanding for a Business Alliance of 5G/AI Related Businesses

TOKYO, Oct. 5, 2020 /PRNewswire/ -- Bit One Group Co., Ltd. (hereinafter referred to as "the Compan...

2020-10-05 14:30 3417

Genor Biopharma Announces Proposed Listing on the Main Board of SEHK

HONG KONG, Sept. 23, 2020 /PRNewswire/ -- JHBP (CY) Holdings Limited ("Genor Biopharma"or the "Comp...

2020-09-23 12:00 3121

Viva Biotech and SYNthesis Enters a Strategic Acquisition Agreement, Accelerating the Development of Global Innovative Drug R & D Service Capabilities

SHANGHAI, Sept. 21, 2020 /PRNewswire/ -- Viva Biotech (Shanghai) Co., Ltd. (hereinafter referred to...

2020-09-21 09:25 3797

Viva Biotech's Portfolio Company Dogma Therapeutics Reached the Acquisition Agreement with AstraZeneca on Dogma's Oral PCSK9 Inhibitor Program

CAMBRIDGE, Mass., Sept. 17, 2020 /PRNewswire/ -- Dogma Therapeutics ("Dogma"), a Viva Biotech Portf...

2020-09-17 20:25 4579

Sihuan Pharmaceutical (0460.HK): Under innovation transformation, an internationalized new pattern in construction

HONG KONG, Sept. 15, 2020 /PRNewswire/ -- Recently, share price of Sihuan Pharmaceutical (0460.HK) ...

2020-09-15 18:05 9396

Venus Medtech Taps into Surgical Heart Valve Market by Cooperating with Haoyue Group to Develop the Business of High-end Biomaterial Medical Devices

HANGZHOU, China, Sept. 10, 2020 /PRNewswire/ -- The leading transcatheter heart valve medical devic...

2020-09-10 17:56 10298

Ping An of China Asset Management (Hong Kong) Awarded "Asset Management Firm of the Year" at Asia Risk Awards 2020

HONG KONG, Sept. 8, 2020 /PRNewswire/ -- Ping An of China Asset Management ( Hong Kong) ("PAAMC HK...

2020-09-08 19:00 2476

Viva Biotech Announced 2020 Interim Results

Financial Highlights for the 6 months ended June 30, 2020 * Revenue amounted to RMB197.6 million,...

2020-08-31 23:27 7268

SDIC leads the investment of Xuanzhu Biopharmaceutical with RMB 800 million, promoting innovation and R&D

HONG KONG, Aug. 24, 2020 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEX: 0460 "S...

2020-08-24 10:20 10294

Sihuan Pharmaceutical Introduced Investors for Capital Increase to Accelerate Solid-liquid Double Chamber Infusion Soft Bag Industry

HONG KONG, Aug. 20, 2020 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEX: 0460 "S...

2020-08-20 19:39 13975

Ping An of China Asset Management (Hong Kong) Launches First Co-branded Fund with Hang Seng Investment Management

HONG KONG, Aug. 18, 2020 /PRNewswire/ -- The Hang Seng Ping An Asian Income Fund (the 'Fund') was la...

2020-08-18 16:00 3432

Lee's Pharm Announced 2020 Interim Results Positive Profit Alert

HONG KONG, Aug. 14, 2020 /PRNewswire/ -- Lee's Pharmaceutical Holdings Limited  ("Lee's Pharm" or th...

2020-08-14 23:49 11133

Viva Biotech and Langhua Pharmaceutical Reached the Strategic Acquisition Agreement, Accelerating the Escalation of the Service Chain of Innovative Drug Industry

SHANGHAI, Aug. 10, 2020 /PRNewswire/ -- On August 9th, 2020, Viva Biotech ( Shanghai) Co., Ltd. (her...

2020-08-10 08:00 4031

Viva Biotech and Schrödinger Announce Strategic Collaboration to Generate and Interrogate Structures for Unsolved Targets

SHANGHAI and NEWYORK, July 28, 2020 /PRNewswire/ -- Viva Biotech Holdings (1873.HK) and Schrödinger...

2020-07-29 07:00 11137

New Licensing Agreement Accelerates the Development of IACTA Pharmaceuticals' Novel Dry Eye Disease and Allergic Conjunctivitis Treatments in China and Southeast Asia

IRVINE, Calif. and HONG KONG, July 28, 2020 /PRNewswire/ -- IACTA Pharmaceuticals, Inc. ("IACTA" or...

2020-07-28 17:59 3746

Venus Medtech to Partner with Pi-Cardia to Bring its Leaflex(TM) Aortic Valve Technology to China

HANGZHOU, China and REHOVOT, Israel, July 14, 2020 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (s...

2020-07-14 18:19 19047

Viva BioInnovator (VBI) Successfully Held 1st Demo Day

SHANGHAI, June 15, 2020 /PRNewswire/ -- On 11 June 2020, Viva BioInnovator (VBI) successfully held ...

2020-06-17 16:40 2218